Key Highlights
● BillionToOne slipped on Friday, closing at $105.15.
● Growth stocks lost ground in a rotation toward defensive sectors.
● BillionToOne drifted lower along with other growth names.
● Fed meeting minutes arrive on Wednesday, November 18.
BillionToOne (NASDAQ:BLLN) slipped on Friday, November 13, 2026, closing at $105.15 as one of the growth names trending lower on the Nasdaq Composite. No company-specific news was identified for the session.
The most recent analyst action found was from Piper Sandler (NYSE:PIPR), which cut its price target on the stock to $130 from $140 about three days earlier. That move kept the target well above where the shares closed on Friday, and there is no indication it drove the day's decline.
BillionToOne is a molecular diagnostics company that develops DNA-based tests, including prenatal screening and cancer-related testing. Like many younger health-technology companies, it is valued largely on its growth prospects, which tends to make the stock sensitive to shifts in overall investor appetite for growth.
Growth stocks out of favor
Friday's market was defined by rotation. Money flowed out of semiconductors, AI hardware and other high-growth areas and into consumer staples, retail, payments, energy and banks. Coca-Cola (NYSE:KO), Chevron (NYSE:CVX) and Walmart (NASDAQ:WMT) led the Dow, while Apple (NASDAQ:AAPL), Visa (NYSE:V), Costco (NASDAQ:COST) and JPMorgan (NYSE:JPM) were described by market commentary as "comfortably higher."
That rotation left growth names struggling for support. The Nasdaq Composite closed at 25,136.27, down 229.82 points, while the S&P 500 fell 30.73 points to 7,561.67. The Russell 2000 slipped 8.57 points to 2,790.49. The Dow Jones Industrial Average was the only major average to gain, adding 50.46 points to 52,347.55.
The day's biggest story was in chips. Nvidia (NASDAQ:NVDA) said on Thursday that Jensen Huang had resigned as chief executive, without giving a reason, and chip and AI-hardware stocks bore the brunt of Friday's selling. Market watchers said the selloff looks less dramatic than the headlines suggest, a reminder that much of the damage was concentrated in a few corners of the market.
The rate headwind
Rates were a key reason Growth Stocks struggled. October producer prices rose at the fastest annual pace since November 2022, even though the monthly reading was slightly cooler than expected. The 10-year Treasury Yield climbed to its highest since October.
Fed officials piled on the hawkish commentary. Chicago Fed President Austan Goolsbee said, "Inflation is rising. It's proved far more persistent than we predicted". Fed Governor Michelle Bowman said, "Inflation pressures have persisted for longer than I had hoped and have shown recent signs of broadening." Traders see a December rate hike as near-certain.
Higher yields typically weigh on growth stocks because their value rests heavily on profits expected further in the future. When rates rise, those future Earnings are worth less in today's terms, and investors often trim exposure to the most growth-dependent names.
Reading the move
Without fresh company news, BillionToOne's decline looks consistent with the broader pressure on growth stocks, though no source directly tied the two. A modest slip on a day of heavy rotation is a common pattern for companies whose valuations depend on long-term expansion.
What to watch next for BillionToOne
Investors will look for any new updates from BillionToOne on test volumes, reimbursement and growth plans. Analyst commentary, following Piper Sandler's recent target cut, may also influence sentiment.
On the macro side, FOMC minutes arrive on Wednesday, November 18, and the Fed meets on December 8 and 9. With rates central to how growth stocks trade, those events will be closely watched. Nvidia's earnings on Tuesday, November 17, could also shape overall risk appetite heading into the following week.



_11_17_2026_20_22_09_679848.jpg)


Please wait processing your request...